AML Expressive Writing

Clinical trial NCT04006496 · TERMINATED

Trial details

NCT number: NCT04006496
Sponsor: Duke University
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2019-11-04
Primary completion: 2022-01-19
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.